Patient No | CD3 + | CD4 + | CD8 + | γδ + | Vδ1 + | Vδ2 + |
---|---|---|---|---|---|---|
Numbers are representative of two to three evaluations for each patient. For patient 4, subsequent evaluations showed a drop in γδ T cells to ∼7% in repeated evaluations. | ||||||
1 | 77.8 | 17.0 | 11.8 | 44.8 | 0.6 | 49.6 |
2 | 76 | 23 | 12 | 33 | 0.2 | 31 |
3 | 72 | 13 | 14 | 66 | 0.3 | 0.3 |
4 | 47.7 | 15.8 | 27.7 | 16.9 | 10.7 | 9.4 |
5 | 59.5 | 22.4 | 14.8 | 10.4 | 5.3 | 0.3 |
6 | 82.5 | 2.0 | 86.8 | 1.0 | 1.0 | 0.0 |
Normal (n=8) | 68 (12.2) | 43.7 (9.8) | 24 (5.9) | 3.4 (1.3) | 1.2 (1.2) | 1.8 (1.2) |